Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19

Rezvan Tavakoli1, Pooneh Rahimi1,2, Mojtaba Hamidi-Fard1,2

  • 1Hepatitis & AIDS Department, Pasteur Institute of Iran, Tehran, Iran.

Future Virology
|December 5, 2023
PubMed
Abstract

Insights

Lower TRIM56 gene expression correlates with severe COVID-19, particularly with the Delta variant. This finding highlights TRIM56's potential role in disease severity across different SARS-CoV-2 variants.

Area of Science:

  • Immunology
  • Virology
  • Genetics

Background:

  • Severe COVID-19 is a global health concern.
  • Understanding genetic factors influencing disease severity is crucial.
  • The role of TRIM56 in SARS-CoV-2 infection requires further investigation.

Purpose of the Study:

  • To investigate the correlation between TRIM56 gene expression and COVID-19 severity.
  • To compare TRIM56 expression across different SARS-CoV-2 variants (Alpha, Delta, Omicron BA.5).

Main Methods:

  • Quantitative real-time PCR (qPCR) was used to measure TRIM56 mRNA levels.
  • The study included 330 COVID-19 patients (142 severe, 188 mild) and 160 healthy controls.

Main Results:

  • TRIM56 mRNA expression was significantly lower in both severe and mild COVID-19 patients compared to healthy individuals.
  • A high reduction in TRIM56 mRNA expression was observed in patients infected with the Delta variant.
  • A low reduction in TRIM56 mRNA expression was observed in patients infected with the Omicron BA.5 variant.

Conclusions:

  • Differential TRIM56 expression is associated with COVID-19 severity.
  • TRIM56 may play a role in the varying severity observed with different SARS-CoV-2 variants.
  • Further research is warranted to elucidate the precise mechanisms by which TRIM proteins influence COVID-19 outcomes.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.3K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K